Overexpression of B7-H3 in CD133+ colorectal cancer cells is associated with cancer progression and survival in human patients
- 27 January 2014
- journal article
- Published by Elsevier BV in Journal of Surgical Research
- Vol. 188 (2), 396-403
- https://doi.org/10.1016/j.jss.2014.01.014
Abstract
No abstract availableKeywords
Funding Information
- Jiangsu Province's Key Discipline/Laboratory of Medicine (81273242)
- Natural Science Foundation of China (81001337)
This publication has 38 references indexed in Scilit:
- CD133 as a target for colon cancerEmerging Therapeutic Targets, 2012
- CD133 as a Marker for Cancer Stem Cells: Progresses and ConcernsStem Cells and Development, 2009
- Targeting CD133 antigen in cancerEmerging Therapeutic Targets, 2009
- CD133 expression is an independent prognostic marker for low survival in colorectal cancerBritish Journal of Cancer, 2008
- Biological and Genetic Characteristics of Tumor-Initiating Cells in Colon CancerAnnals of Surgical Oncology, 2007
- Identification and expansion of human colon-cancer-initiating cellsNature, 2006
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133Blood, 2004
- AC133 Hematopoietic Stem Cell Antigen: Human Homologue of Mouse Kidney Prominin or Distinct Member of a Novel Protein Family?Blood, 1998
- AC133, a Novel Marker for Human Hematopoietic Stem and Progenitor CellsBlood, 1997